| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Sep-08 | | Total Revenue | 178,718 | 155,784 | 139,309 | 600,181 | | Cost of Revenue | 94,184 | 98,672 | 105,294 | 391,652 | | | Gross Profit | 84,534 | 57,112 | 34,015 | 208,529 | | | Operating Expenses | | Research Development | 43,162 | 48,196 | 50,146 | 60,410 | | Selling General and Administrative | 55,116 | 53,069 | 60,715 | 127,368 | | Non Recurring | 7,334 | 1,089 | 6,046 | (2,094) | | Others | 834 | 834 | 1,319 | 5,336 | | | | Total Operating Expenses | 106,446 | 103,188 | 118,226 | 191,020 | | | | Operating Income or Loss | (21,912) | (46,076) | (84,211) | 17,509 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,842 | 2,640 | (1,083) | 23,394 | | Earnings Before Interest And Taxes | (19,070) | (43,436) | (85,294) | 40,903 | | Interest Expense | 350 | 525 | 416 | 2,840 | | Income Before Tax | (19,420) | (43,961) | (85,710) | 38,063 | | Income Tax Expense | 236 | 1,324 | 2,625 | 52,161 | | Minority Interest |
-
|
-
|
-
| (9,992) | | | | Net Income From Continuing Ops | (19,656) | (45,285) | (88,335) | (24,090) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,656) | (45,285) | (88,335) | (24,090) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,656) | ($45,285) | ($88,335) | ($24,090) |
|
0.02% Nasdaq 
Income Statement
